Cancer Rates in the US Continue to Drop, ACS Reports - Singularity Hub (blog)

Singularity Hub (blog)

Cancer Rates in the US Continue to Drop, ACS Reports Singularity Hub (blog) In men especially, lower smoking rates have contributed to the decrease in lung cancer. Early detection has also had a big effect, with more men receiving ... Progress made in U.S. cancer fightHattiesburg American Saint Raphael's Cancer Center to open new American Cancer Society resource centerShorelinePlus.com all 59 news articles »

Prostate cancer 'cell of origin' identified - msnbc.com

Prostate cancer 'cell of origin' identified msnbc.com Prostate cancer is the second most common cause of cancer death in the United States after lung cancer. According to the American Cancer Society, ... and more »

Lung Cancer Alliance-Georgia Announces 2nd Annual No More Excuses 5K Run/1 ... - PR Newswire (press release)

Lung Cancer Alliance-Georgia Announces 2nd Annual No More Excuses 5K Run/1 ... PR Newswire (press release) Lung cancer is the leading cause of cancer death nationally and in Georgia. This year alone, more Georgians will lose their lives to lung cancer than breast ... and more »

Allos' cancer drug extends lung cancer survival - Reuters

Allos' cancer drug extends lung cancer survival Reuters O, in patients with advanced non-small cell lung cancer, who had received one or two prior systemic treatments. The main-goal of the trial was overall ... Allos Therapeutics' Folotyn meets study goalBusinessWeek Allos: Folotyn Survival Trend in Lung CancerTheStreet.com Allos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in ...MarketWatch (press release) RTT News -Denver Business Journal all 63 news articles »

Geron Corporation Reports 2010 Second Quarter Financial Results and Events - MarketWatch (press release)

Geron Corporation Reports 2010 Second Quarter Financial Results and Events MarketWatch (press release) ... Phase 2 clinical trial of imetelstat as maintenance therapy following platinum-based induction therapy for patients with non-small cell lung cancer. ... and more »